| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used in operating activities | -4,364,984 | -2,971,566 |
| Purchases of property and equipment | 187,317 | 24,483 |
| Patent costs incurred | 153,634 | 58,649 |
| Net cash used in investing activities | -340,951 | -83,132 |
| Proceeds from sale of common stock and warrants, net of issuance costs | 3,540,430 | 3,423,784 |
| Payments of finance agreement | 306,764 | 230,073 |
| Net cash provided by financing activities | 3,233,666 | 3,193,711 |
| Net (decrease) increase in cash | -1,472,269 | 139,013 |
| Cash and cash equivalents at beginning of period | 7,827,487 | - |
| Cash and cash equivalents at end of period | 6,355,218 | - |
Cardio Diagnostics Holdings, Inc. (CDIOW)
Cardio Diagnostics Holdings, Inc. (CDIOW)